Nikolaos P. Nanis - 01 Dec 2023 Form 3 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Chief Technology Officer
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
01 Dec 2023
Net transactions value
$0
Form type
3
Filing time
05 Dec 2023, 16:05:11 UTC
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TDOC Common Stock 63,428 01 Dec 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TDOC Employee Stock Option (right to buy) 01 Dec 2023 Common Stock 21,162 $32.62 Direct F1
holding TDOC Restricted Stock Units 01 Dec 2023 Common Stock 467 Direct F2, F3
holding TDOC Restricted Stock Units 01 Dec 2023 Common Stock 568 Direct F3, F4
holding TDOC Restricted Stock Units 01 Dec 2023 Common Stock 3,033 Direct F3, F5
holding TDOC Restricted Stock Units 01 Dec 2023 Common Stock 6,260 Direct F3, F6
holding TDOC Restricted Stock Units 01 Dec 2023 Common Stock 9,862 Direct F3, F7
holding TDOC Restricted Stock Units 01 Dec 2023 Common Stock 13,021 Direct F3, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested as to one-third of the shares on June 1, 2023. The remainder of the shares vest in 24 substantially equal monthly installments thereafter.
F2 On March 2, 2021, the reporting person was granted 1,400 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
F3 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F4 On August 10, 2021, the reporting person was granted 1,703 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
F5 On March 1, 2022, the reporting person was granted 6,064 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F7 On October 1, 2022, the reporting person was granted 14,793 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F8 On March 3, 2023, the reporting person was granted 13,021 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Remarks:

Exhibit 24 -- Power of Attorney